News

The 6th Annual Meeting of the Shanghai Stroke Society, the Huashan International Conference on Cerebrovascular Diseases (HISC 2025), and the Huashan Conference on Cognition and Brain Diseases (CBD 2025) were successfully held from October 30 to November 1, 2025, at the Shanghai Banma Suhe International Conference Center. The event was guided by the National Center for Neurological Disorders and organized by the Shanghai Stroke Society, with support from Huashan Hospital Affiliated to Fudan University and the Shanghai Zhou Liangfu Medical Development Foundation.

With continuous innovation in medical technologies, deeper multidisciplinary collaboration, and stronger links between basic researh and clinical practice, the global field of cerebrovascular diseases has seen remarkable advances in understanding disease mechanisms, improving diagnostic tools, optimizing treatment strategies, and strengthening preventive systems. This conference provided a high-level, interdisciplinary, and international platform for researchers, clinicians, and innovators working in cerebrovascular science and care.

The event featured numerous highlights, bringing together leading experts from China and abroad for keynote lectures and diverse academic activities. The program design included live surgery broadcasts, international frontier sessions, multicenter case discussions, and multidisciplinary round-table forums, creating an immersive academic exchange environment for participants. Core topics addressed the most pressing issues in cerebrovascular disease, including new advances in ischemic and hemorrhagic stroke treatment, standardized stroke care and neuroprotection, secondary prevention and long-term management, precision diagnostics, and individualized therapies.

Aligned with the theme of “Promoting deep collaboration among medicine, research, and industry to accelerate innovation in precision diagnosis and treatment,” the conference aimed to enhance the efficient translation of scientific findings into clinical practice, empower clinical decision-making with technological innovation, and ultimately foster broader collaboration to benefit stroke patients worldwide.

During the conference, Professor Zhao Zhiqiang from Beijing Tiantan Hospital affiliated with Capital Medical University shared his clinical experience and practical insights using TJWY’s Nuva® Flow Diverter. Through surgical reviews of seven intracranial aneurysm cases treated with Nuva®, Professor Zhao highlighted that the device delivered smoothly, with adjustable intraoperative tension guided by the positioning of the roadmap wire to ensure optimal wall apposition during deployment. He also noted that the device’s continuous radiopacity allowed real-time visualization throughout the procedure, helping reduce intraoperative complications. Furthermore, he recognized the Ni-Ti alloy’s high conformability when navigating tortuous distal intracranial vessels. Professor Zhao also shared his expectations for future enhancements of the device.

One of the major highlights for TJWY Medical during the conference was the hands-on Workshop session. Using vascular models, participants were able to simulate interventional procedures and directly experience new technologies and workflows in neurovascular intervention. This fully aligned with the conference’s mission of deep medical–engineering–research–industry collaboration, promoting technological innovation to empower clinical practice and ultimately benefiting more patients.

Note: The above order is not ranked in any particular order.